Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fujian Mindong Lijiexun Pharmaceutical is a prominent Chinese pharmaceutical company headquartered in Zherong, Fujian Province. Established in 1997, the company specializes in the development, manufacturing, and commercialization of high-quality chemical drugs, with a particular focus on freeze-dried powder injections. Its core therapeutic areas include anti-infectives, neurology, and gastroenterology, featuring a robust portfolio of cephalosporin antibiotics and neuroprotective agents. Lijiexun operates state-of-the-art GMP-certified production facilities and has a strong market presence in China's domestic hospital channel. The company is also actively engaged in the consistency evaluation of generic drugs and the development of innovative Class 1 chemical entities to enhance its competitive position in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 福建省闽东力捷迅药业.